close
  • home Home

  • linked_services Solutions keyboard_arrow_down

  • experiment Services keyboard_arrow_down

  • support Support & Resources keyboard_arrow_down

  • apartment Company keyboard_arrow_down

  • mail Contact

  • Solutions
    keyboard_arrow_down
  • Services
    keyboard_arrow_down
  • Support & Resources
    keyboard_arrow_down
  • Company
    keyboard_arrow_down
  • Contact
Randox Health search menu

The RIQAS Urine Toxicology EQA programme is designed to monitor the performance of 20 drugs of abuse tests in urine. Suitable for both qualitative and semi-quantitative methods of analysis.

Key Benefits

Liquid ready-to-use samples requiring minimal preparation

Submit results and view reports online via Riqas.com

Worlds largest EQA scheme ensuring peer groups are maximised

Monthly reporting for earlier identification of test system errors

Cycle Starts - January 2026

Not Accredited

Get in touch to discover more

To find out more about RIQAS EQA or to get in touch with your local Randox Representative, enquire now.

DescriptionFrequencySizeCat No
Urine ToxicologyMonthly12 x 5 mlRQ9139

Parameters

  • Benzoylecgonine
  • EDDP
  • Nortriptyline
  • Buprenorphine
  • Ethanol
  • Norpropoxyphene
  • Cannabinoids (THC)
  • Free Morphine
  • Oxazepam
  • Cotinine
  • Lorazepam
  • Phencyclidine
  • Creatinine
  • LSD
  • Phenobarbital
  • d-Amphetamine
  • MDMA
  • Secobarbital
  • d-Methamphetamine
  • Methadone

Please note, product availability may vary country to country.

Related RIQAS EQA Programmes

Therapeutic Drugs

Immunoassay

Immunoassay Speciality 1

Acusera QC
Complete QC Solutions for Results you Can Trust
RIQAS Brochure
Randox International Quality Assessment Scheme
QCMD
QCMD EQA/PT Schemes for Molecular Infectious Disease Testing.